Recro Pharma, Inc. announced on January 18, 2022, Gerri A. Henwood, a Class II member of the Board of Directors notified the Company of her intent to resign from the Board, effective January 18, 2022. After working with the Company for the last 12 months on transition, Ms. Henwood is resigning to focus on her role as Chief Executive Officer and director of Baudax Bio, Inc.